Preventing Sudden Cardiac Arrest in Young Athletes - the Case for ECG Screening

Preventing Sudden Cardiac Arrest in Young Athletes - The Case for ECG Screening

Dr. David Hadley

President of Cardea Screen. He has over 30 years of hands-on experience blending customer needs with information technology through research and development. He spent nine years as Vice President of Research and Development for Quinton Cardiology. In this role, Dr. Hadley was responsible for rebuilding the engineering team, establishing robust new product architectures and developing the next generation of Quinton and Burdick diagnostic ECG products.

Prior to his role at Quinton Cardiology, Dr. Hadley was with Primus Knowledge Solutions and Sierra Geophysics. He earned his Ph.D. from the California Institute of Technology.

On average, every three days in the US, a seemingly healthy young person suffers a sudden cardiac arrest (SCA). SCA is the leading medical cause of death in active young athletes, however; there are no warning signs and cardiac abnormalities are generally not detected by a physical exam. Learn how ECG screening can identify athletes that require follow up for life threatening cardiac abnormalities.

In this webinar, you will learn:

The prevalence of cardiac abnormalities in young athletes by demographic and sport
Why a typical pre-participation exam doesn't identify at-risk athletes
Game changer - what is the ECG Seattle Criteria
How to easily and cost-effectively add ECG evaluation to your pre-participation screening events using CardeaScreen
Why CardeaScreen is the right choice for ECG screening for young athletes